2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Neoplasms
14
Lung Neoplasms
11
Breast Neoplasms
9
Colorectal Neoplasms
8
Prostatic Neoplasms
7
Stomach Neoplasms
3
Rectal Neoplasms
3
Polycystic Ovary Syndrome
3
Neoplasm Metastasis
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Smoking Cessation
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic cancer, adult
2
Ovarian Neoplasms
2
Neoplastic Cells, Circulating
2
Motor Activity
2
Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Endometrial Neoplasms
2
Disease
2
Wilms Tumor
1
Venous Thromboembolism
1
Vaginal Neoplasms
1
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
1
Testicular Germ Cell Tumor
1
Interventions
Peripheral Blood Stem Cell Transplantation
39
fludarabine phosphate
36
Cyclophosphamide
31
Mycophenolic Acid
28
Cyclosporine
25
Whole-Body Irradiation
24
Tacrolimus
22
Busulfan
18
Antilymphocyte Serum
18
Radiotherapy
16
Methotrexate
16
Flow Cytometry
14
Filgrastim
14
Etoposide
13
Methylprednisolone
10
Lenalidomide
10
Bortezomib
10
Vorinostat
9
Melphalan
9
mogamulizumab
8
Therapeutics
8
Rituximab
8
Psychiatric Rehabilitation
8
Polymerase Chain Reaction
8
Gemcitabine
8
Cord Blood Stem Cell Transplantation
7
Bexarotene
7
pembrolizumab
6
Alemtuzumab
6
tanespimycin
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sezary Syndrome
×
Hematologic Tests
×
Clear all
NCT04904146
2025-03-10
BIO-MUSE
Lund University Hospital
Recruiting
120 enrolled